IOVANCE BIOTHERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01 Other Events.

On June 29, 2021, Iovance Biotherapeutics, Inc. (the "Company") issued a press release announcing clinical data for its TIL therapy LN-145 in patients with metastatic non-small cell lung cancer who enrolled in Cohort 3B of the Company's ongoing basket study IOV-COM-202. The full text of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

A copy of the slide presentation referred to in the press release is attached hereto as Exhibit 99.2 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.



Exhibit No.                                 Description

  99.1          Press Release of Iovance Biotherapeutics, Inc., dated June 29,
              2021.
  99.2          Slide Presentation of Iovance Biotherapeutics, Inc., dated June 29,
              2021.
104           Cover Page Interactive Data File - the cover page interactive date file
              does not appear in the Interactive Date File because its XBRL tags are
              embedded within the Inline XBRL document.

© Edgar Online, source Glimpses